ProjectSENSITIZE (Studie)

Basic data

Title:
SENSITIZE (Studie)
Duration:
14/11/2017 to 31/12/2020
Abstract / short description:
Unverblindete, multizentrische Studie der Phase Ib/II zu 4SC-202 in Kombination mit Pembrolizumab bei Patienten mit nicht resezierbarem kutanem Melanom im Stadium III / metastasiertem kutanem Melanom im Stadium IV mit primärer Refraktärität gegen / Nichtansprechen auf eine frühere Anti-PD-1-Therapie
Keywords:
melanoma
Melanom

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Contact persons

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Planegg, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.